Cited by 46ECG Monitoring and AnalysisPulmonary Hypertension Research and TreatmentsArtificial Intelligence in Healthcare

Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning

Open access
ARAS, MANDAR A., ABREAU, SEAN, MILLS, HUNTER, RADHAKRISHNAN, LAKSHMI, KLEIN, LIVIU, MANTRI, NEHA, RUBIN, BENJAMIN, BARRIOS, JOSHUA +9 more·2023·Journal of Cardiac Failure

Abstract

Background Pulmonary hypertension (PH) is life-threatening, and often diagnosed late in its course. We aimed to evaluate if a deep learning approach using electrocardiogram (ECG) data alone can detect PH and clinically important subtypes. We asked: does an automated deep learning approach to ECG interpretation detect PH and its clinically important subtypes? Methods and results Adults with right heart catheterization or an echocardiogram within 90 days of an ECG at the University of California, San Francisco (2012-2019) were retrospectively identified as PH or non-PH. A deep convolutional neural network was trained on patients' 12-lead ECG voltage data. Patients were divided into training, development, and test sets in a ratio of 7:1:2. Overall, 5016 PH and 19,454 patients without PH were used in the study. The mean age at the time of ECG was 62.29 ± 17.58 years and 49.88% were female. The mean interval between ECG and right heart catheterization or echocardiogram was 3.66 and 2.23 days for patients with PH and patients without PH, respectively. In the test dataset, the model achieved an area under the receiver operating characteristic curve, sensitivity, and specificity, respectively of 0.89, 0.79, and 0.84 to detect PH; 0.91, 0.83, and 0.84 to detect precapillary PH; 0.88, 0.81, and 0.81 to detect pulmonary arterial hypertension, and 0.80, 0.73, and 0.76 to detect group 3 PH. We additionally applied the trained model on ECGs from participants in the test dataset that were obtained from up to 2 years before diagnosis of PH; the area under the receiver operating characteristic curve was 0.79 or greater. Conclusions A deep learning ECG algorithm can detect PH and PH subtypes around the time of diagnosis and can detect PH using ECGs that were done up to 2 years before right heart catheterization/echocardiogram diagnosis. This approach has the potential to decrease diagnostic delays in PH.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cardfail.2022.12.016

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence for AI-ECG detection of pulmonary hypertension and right ventricular dysfunction remains comparatively early and predominantly retrospective, although reported discrimination has been encouraging with AUROCs of approximately 0.86-0.92 across internal and external validation cohorts.

    “Evidence for AI-ECG detection of PH and right ventricular dysfunction remains comparatively early. Published studies are still predominantly retrospective, although reported discrimination has been encouraging, with AUROCs of approximately 0.86–0.92 across internal and external validation cohorts.31–33”

    From AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions (2026) · cites this paper as [33]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Hypertrophic cardiomyopathy, cardiac amyloidosis, and pulmonary hypertension AI-ECG applications remain earlier or pathway-incomplete.

    “hypertrophic cardiomyopathy, cardiac amyloidosis, and pulmonary hypertension remain earlier or pathway-incomplete applications.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. [1]1. Simonneau, G ∙ Montani, D ∙ Celermajer, DS ... Haemodynamic definitions and updated clinical classification of pulmonary hypertension Eur Respir J. 2019; 53, 1801913 Crossref Scopus (2598) PubMed Google Scholar
  2. [2]2. Benza, RL ∙ Miller, DP ∙ Barst, RJ ... An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest. 2012; 142:448-456 Full Text Full Text (PDF) Scopus (820) PubMed Google Scholar
  3. [3]3. Gall, H ∙ Felix, JF ∙ Schneck, FK ... The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups J Heart Lung Transplant. 2017; 36:957-967 Full Text Full Text (PDF) Scopus (224) PubMed Google Scholar
  4. [4]4. Khou, V ∙ Anderson, JJ ∙ Strange, G ... Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry Respirology. 2020; 25:863-871 Crossref Scopus (44) PubMed Google Scholar
  5. [5]5. Strange, G ∙ Gabbay, E ∙ Kermeen, F ... Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study Pulmonary Circ. 2013; 3:89-94 Crossref Scopus (101) PubMed Google Scholar
  6. [6]6. Galiè, N ∙ Humbert, M ∙ Vachiery, J-L ... 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) Eur Respir J. 2015; 46:903-975 Crossref Scopus (2415) PubMed Google Scholar
  7. [7]7. Kim, MH ∙ Johnston, SS ∙ Chu, BC ... Estimation of total incremental health care costs in patients with atrial fibrillation in the United States Circ Cardiovasc Qual Outcomes. 2011; 4:313-320 Crossref Scopus (624) PubMed Google Scholar
  8. [9]9. Armstrong, I ∙ Billings, C ∙ Kiely, DG ... The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients BMC Pulmonary Med. 2019; 19:67 Crossref Scopus (43) PubMed Google Scholar
  9. [10]10. Brown, LM ∙ Chen, H ∙ Halpern, S ... Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry Chest. 2011; 140:19-26 Full Text Full Text (PDF) Scopus (211) PubMed Google Scholar
  10. [11]11. Kiely, DG ∙ Lawrie, A ∙ Humbert, M Screening strategies for pulmonary arterial hypertension Eur Heart J Suppl. 2019; 21:K9-K20 Crossref Scopus (47) PubMed Google Scholar
  11. [12]12. Ollivier, C ∙ Sun, H ∙ Amchin, W ... New strategies for the conduct of clinical trials in pediatric pulmonary arterial hypertension: outcome of a multistakeholder meeting with patients, academia, industry, and regulators, held at the European Medicines Agency on Monday, June 12, 2017 J Am Heart Assoc. 2019; 8, e011306 Crossref Scopus (24) PubMed Google Scholar
  12. [13]13. Sobczyk, D ∙ Nycz, K ∙ Andruszkiewicz, P Validity of a 5-minute focused echocardiography with A-F mnemonic performed by non-echocardiographers in the management of patients with acute chest pain Cardiovasc Ultrasound. 2015; 13:16 Crossref Scopus (19) PubMed Google Scholar
  13. [15]15. Bhatia, RS ∙ Bouck, Z ∙ Ivers, NM ... Electrocardiograms in low-risk patients undergoing an annual health examination JAMA Intern Med. 2017; 177:1326-1333 Crossref Scopus (58) PubMed Google Scholar
  14. [16]16. Pitts, SR ∙ Niska, RW ∙ Xu, J ... National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary Natl Health Stat Report. 2008; 6:1-38 PubMed Google Scholar
  15. [17]17. Bossone, E ∙ Paciocco, G ∙ Iarussi, D ... The prognostic role of ECG in primary pulmonary hypertension Chest. 2002; 121(2):513-518 Full Text Full Text (PDF) Scopus (132) PubMed Google Scholar
  16. [18]18. Tison, GH ∙ Zhang, J ∙ Delling, FN ... Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery Circ Cardiovasc Qual Outcomes. 2019; 12, e005289 Crossref Scopus (120) PubMed Google Scholar

Cited by

Sorted by citations

Authors
ARAS, M. A., ABREAU, S., MILLS, H., RADHAKRISHNAN, L., KLEIN, L., MANTRI, N., RUBIN, B., BARRIOS, J., CHEHOUD, C., KOGAN, E., GITTON, X., NNEWIHE, A., QUINN, D., BRIDGES, C., BUTTE, A. J., OLGIN, J. E., & TISON, G. H.
Affiliations
  • University of California, San Francisco (US)
  • Actelion (Switzerland) (CH)
Corresponding author
TISON, GEOFFREY H.
Venue
Journal of Cardiac Failure
Publisher
Elsevier BV
Published
2023-07
Volume
29
Issue
7
Pages
1017-1028
ISSN
1071-9164 (ISSN-L)
OpenAlex
W4317936535
Cited by
46
References
5
Citations by year
2026: 15 · 2025: 12 · 2024: 14 · 2023: 5
FWCI
9.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Cardiac Failure (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, other-oa)
Funders
  • California Institute for Regenerative Medicine
  • March of Dimes Foundation
  • Leon Lowenstein Foundation
  • MyoKardia
  • National Institutes of Health
  • Genentech
  • National Heart, Lung, and Blood Institute (K23HL135274)
  • Actelion Pharmaceuticals
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
pulmonary hypertension, electrocardiogram, deep learning, convolutional neural networks, precapillary pulmonary hypertension, pulmonary arterial hypertension, group 3 pulmonary hypertension, automated ECG analysis, right heart catheterization, echocardiography, early diagnosis, delayed diagnosis
MeSH terms
Deep Learning, Adult, Electrocardiography, Female, Heart Failure, Humans, Hypertension, Pulmonary, Male, Retrospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review